55‐1: A Novel Modeling & Compensation Algorithm for Medium‐Term Image Sticking on AMOLED Display
SID Symposium Digest of Technical Papers · 2024-06 · 55 (1) · 750-754
DOI: 10.1002/sdtp.17635 ↗Kurz gefasst
Fachartikel in der Zeitschrift SID Symposium Digest of Technical Papers, online erschienen am 30.07.2024. Verfasst von Xuan-Yong Lin und 3 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 4 Literaturangaben.
Abstract (Originalsprache)
In this paper, we discuss the different type of image sticking(IS) and propose a novel algorithm for improving medium‐term IS on AMOLED display. This method could not only solve the IS effect on traditional display but also the multi‐areas frame rate (MAFR) display. For future OLED power‐saving applications, the application of MAFR becomes increasingly important. This involves categorizing the same display into high and low refresh rate zones based on display usage efficiency. When the display remains static for a period and then switches, the issue of display retention may arise. Our experimental results confirms that IS can be quantified into a model, and the algorithm is used for real‐time compensation to reduce the retention issues.
Zitieren
APA
Lin, X., Su, S., Pai, F., & Lin, C. (2024). 55‐1: A Novel Modeling & Compensation Algorithm for Medium‐Term Image Sticking on AMOLED Display. SID Symposium Digest of Technical Papers, 55(1), 750-754. https://doi.org/10.1002/sdtp.17635
Vancouver
Lin X, Su S, Pai F, Lin C. 55‐1: A Novel Modeling & Compensation Algorithm for Medium‐Term Image Sticking on AMOLED Display. SID Symposium Digest of Technical Papers. 2024;55(1):750-754. doi:10.1002/sdtp.17635
BibTeX
@article{Lin2024,
author = {Lin, Xuan-Yong and Su, Shang-Yu and Pai, Feng-Ting and Lin, Ching-Chun},
title = {55‐1: A Novel Modeling & Compensation Algorithm for Medium‐Term Image Sticking on AMOLED Display},
journal = {SID Symposium Digest of Technical Papers},
year = {2024},
volume = {55},
number = {1},
pages = {750--754},
doi = {10.1002/sdtp.17635}
}
EUVIMED